Stocktwits, Inc. (“Stocktwits”) is not a securities broker-dealer, investment adviser, or any other type of financial professional. No content on the Stocktwits platform should be considered an offer, solicitation of an offer, or advice to buy or sell securities or any other type of investment or financial product.
By using the Stocktwits platform, you understand and agree that Stocktwits does not provide investment advice, recommend any security, transaction, or order, issue securities, produce or provide research. For additional disclosures, please see here.
La Jolla Pharmaceutical Company is a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapeutics for chronic organ failure and cancer. GCS-100, the Company's lead product candidate, is a first-in-class inhibitor of galectin-3, a novel molecular target implicated in chronic organ failure and cancer. LJPC-501, the Company's second product candidate, is a natural peptide for the treatment of the hepatorenal syndrome.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of La Jolla Pharmaceutical Co.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. La Jolla Pharmaceutical Co. market cap is $158.96M.
What is the 52-week high for La Jolla Pharmaceutical Co.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. La Jolla Pharmaceutical Co. 52 week high is $6.24 as of September 18, 2025.
What is the 52-week low for La Jolla Pharmaceutical Co.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. La Jolla Pharmaceutical Co. 52 week low is $3.07 as of September 18, 2025.
What is La Jolla Pharmaceutical Co. stock price today?
La Jolla Pharmaceutical Co. stock price today is $6.22.
What was La Jolla Pharmaceutical Co. stock price yesterday?
La Jolla Pharmaceutical Co. stock price yesterday was $6.22.
What is the PE ratio of La Jolla Pharmaceutical Co.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. La Jolla Pharmaceutical Co.’s P/E ratio is 59.18.
What is the Price-to-Book ratio of La Jolla Pharmaceutical Co.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. La Jolla Pharmaceutical Co. P/B ratio is -2.1151.
What is the 50-day moving average of La Jolla Pharmaceutical Co.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. La Jolla Pharmaceutical Co. 50-day moving average is $5.11.